In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell Carcinoma

被引：1
|
作者：
Fan, Alice C. [2 ]
Leppert, John T. [1 ]
机构：
[1] Stanford Univ, Dept Urol, Sch Med, 300 Pasteur Dr,Grant S-287, Stanford, CA 94305 USA
[2] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 01期
关键词：
D O I：
10.1001/jamanetworkopen.2020.35120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Song, Yuxuan
    Han, Songchen
    Xu, Tao
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1991 - 1992
  • [42] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Yuxuan Song
    Songchen Han
    Tao Xu
    World Journal of Urology, 2023, 41 : 1991 - 1992
  • [43] Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy
    Hong, Cierra
    Batich, Kristen A.
    Almquist, Garland
    Villa, Luis
    George, Daniel J.
    Zhang, Tian
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 3
  • [44] Tissue biomarkers of immune checkpoint inhibitor therapy
    Davoudi, Fatemeh
    Moradi, Afshin
    Sadeghirad, Habib
    Kulasinghe, Arutha
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (03): : 179 - 193
  • [45] Combining Checkpoint and Tyrosine Kinase Inhibitor in the Treatment of Renal Cell Carcinoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (05) : 247 - 247
  • [46] Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
    Bridge, Jennifer A.
    Lee, James C.
    Daud, Adil
    Wells, James W.
    Bluestone, Jeffrey A.
    FRONTIERS IN MEDICINE, 2018, 5
  • [47] Biomarkers of the response in metastatic papillary renal cell carcinoma
    De Vries-Brilland, M.
    Rioux-Leclercq, N.
    Blanc, E.
    Fromont, G.
    Mescam, G. Gravis
    Geoffrois, L.
    Chevreau, C. M.
    Goupil, M. Gross
    Escudier, B.
    Negrier, S.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1219 - S1220
  • [48] A Rare Case of Giant Cell Arteritis After the Administration of Checkpoint Inhibitor Therapy in a Metastatic Renal Cell Carcinoma Patient
    Khan, Marjan
    Talpur, Abdul Subhan
    Leon, Chady Abboud
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [49] DNA hypermethylation biomarkers to predict therapy response of antiangiogenic therapy in metastatic renal cell carcinoma patients
    Peters, Inga
    Dubrowinskaja, Natalia
    Abbas, Mahmoud
    Seidel, Christoph
    Kogosov, Michael
    Scherer, Ralph
    Gebauer, Kai
    Merseburger, Axel S.
    Kuczyk, Markus A.
    Gruenwald, Viktor
    Serth, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [50] Peripheral blood mononuclear cell biomarkers predict response to immune checkpoint inhibitor therapy in metastatic breast cancer
    Yuan, Y.
    Hou, W.
    Padam, S.
    Frankel, P.
    Sedrak, M. S.
    Portnow, J.
    Mortimer, J.
    Yeon, C.
    Hurria, A.
    Tang, A.
    Martinez, N.
    Lee, P.
    ANNALS OF ONCOLOGY, 2018, 29
12345